Frank Boxberger

973 citations

35 papers · 783 indexed · h-index 12

Impact in

Gastroenterology top 10%
Oncology
- Colorectal Cancer Treatments and Studies

Papers in

Gastroenterology 4
- Gastrointestinal Tumor Research and Treatment 3
Oncology 19
- Colorectal Cancer Treatments and Studies 10
- Pancreatic and Hepatic Oncology Research 5
- Cancer Treatment and Pharmacology 3

Co-authors: H Lührs W Scheppach R Melcher Thomas Menzel Jürgen Schauber Justus Müller Axel Wein Markus F. Neurath
Journals: Journal of Clinical Oncology (5 papers)Endoscopy (3 papers)European Journal of Gastroenterology & Hepatology (2 papers)Anti-Cancer Drugs (2 papers)European Journal of Cancer Prevention (1 paper)
Partner nations: Germany United States Switzerland

In The Last Decade

Frank Boxberger

32 papers receiving 762 citations

Peers

Countries citing papers authored by Frank Boxberger

Since Specialization

Citations

This map shows the geographic impact of Frank Boxberger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank Boxberger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank Boxberger more than expected).

Fields of papers citing papers by Frank Boxberger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frank Boxberger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank Boxberger. The network helps show where Frank Boxberger may publish in the future.

Co-authors

The 25 scholars most cited alongside Frank Boxberger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Frank Boxberger Line = papers co-authored together Frank Boxberger links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	VEGFR2 Signaling Prevents Colorectal Cancer Cell Senescence to Promote Tumorigenesis in Mice With Colitis Gastroenterology ·Sebastian Foersch, Tobias Sperka, Ana Cristina Macías Fernández, MARIA EDUARDA MOREIRA ANGEIRAS, K. Lenhard Rudolph, Georg Breier, Frank Boxberger, Tilman T. Rau, Arndt Hartmann, Michael Stürzl, Nadine Wittkopf, Hidayati Nurfatah, Stefan Wirtz, Markus F. Neurath, Maximilian J. Waldner	2015	47
2	Bevacizumab plus chemotherapy as first-line treatment for patients with metastatic colorectal cancer: Results from a large German community-based observational cohort study Acta Oncologica ·Alexander Stein, Volker Petersen, Chen-Jie Li, Jörg Seraphin, Heinz‐Gert Hoeffkes, Norberto Recalde, Janelle Blum, Christopher Lubega, Frank Boxberger, Barbara Leutgeb, Axel Hinke, 亮大杉, Dirk Arnold	2014	12
3	Metastatic Adenocarcinomas of the Stomach or Esophagogastric Junction (UICC Stage IV) Are Not Always a Palliative Situation: A Retrospective Analysis World Journal of Surgery ·Claus Schildberg, R D Blake, Werner Hohenberger, Axel Wein, Melanie Langheinrich, Markus F. Neurath, Frank Boxberger	2013	6
4	Antiemetic prophylaxis and frequency of chemotherapy-induced nausea and vomiting in palliative first-line treatment of colorectal cancer patients: the Northern Bavarian IVOPAK I Project Supportive Care in Cancer ·Sonja Koch, Axel Wein, Jürgen Siebler, Frank Boxberger, Markus F. Neurath, Ram Prasad Gotame, Werner Hohenberger, Frank Dörje	2013	10
5	Palliative treatment of colorectal cancer in Germany: cost of care and quality of life The European Journal of Health Economics ·Martin Emmert, Jan Nováček, Axel Wein, Frank Dörje, Susanne Merkel, Frank Boxberger, R. L. Coalson, 蒙勇, R. Longvialle, Christine Kjær Jacobsen, Christof Lamberti, Markus F. Neurath, Werner Hohenberger, Oliver Schöffski	2012	14
6	Long-Term Relapse-Free Survival by Interdisciplinary Collaboration in a Patient with Metastatic Pancreatic Cancer (UICC IV) SHILAP Revista de lepidopterología ·R.R. Gafiyatullina, Axel Wein, Heinz Albrecht, Nelson Javier Neva Díaz, Kerstin Wolff, Guo-xiong Cheng, Kerstin Amann, Rolf Janka, Werner Hohenberger, Eckhart G. Hahn, Jürgen Siebler, Markus F. Neurath, Frank Boxberger	2011	1
7	Colonoscopy‐associated perforation: a 7‐year survey of in‐hospital frequency, treatment and outcome in a German university hospital Colorectal Disease ·Alexander Hagel, Frank Boxberger, Wolfgang Dauth, Hermann Keßler, Markus F. Neurath, Martin Raithel	2011	18
8	Palliative first-line therapy with weekly high-dose 5-fluorouracil and sodium folinic acid as a 24-hour infusion (AIO regimen) combined with weekly irinotecan in patients with metastatic adenocarcinoma of the stomach or esophagogastric junction followed by secondary metastatic resection after downsizing Medical Science Monitor ·Ермакова А.Н., Axel Wein, Peter C. Konturek, Heinz Albrecht, Udo Reulbach, R. L. Coalson, Kerstin Wolff, P. Luopa, Dagmar Busse, Henriette Golcher, Claus Schildberg, Rolf Janka, Werner Hohenberger, Eckhart G. Hahn, Jürgen Siebler, Markus F. Neurath, Frank Boxberger	2011	7
9	Complete Long-Term Remission of an Inflammatory Pseudotumor under Corticosteroid Therapy SHILAP Revista de lepidopterología ·Lukas Pfeifer, Abbas Agaimy, Rolf Janka, Frank Boxberger, Axel Wein, Markus F. Neurath, Jürgen Siebler	2011	11
10	Palliative first-line treatment with weekly high-dose 5-fluorouracil as 24h-infusion and gemcitabine in metastatic pancreatic cancer (UICC IV). PubMed ·R.R. Gafiyatullina, Axel Wein, Heinz Albrecht, Peter C. Konturek, Udo Reulbach, R. L. Coalson, Kerstin Wolff, P. Luopa, Werner Hohenberger, Eckhart G. Hahn, Frank Boxberger	2010	7
11	Splenic rupture as a complication of endoscopic esophageal bouginage Endoscopy ·R. Goertz, Payo Hill, S-M Brand-Herrmann, Markus Wehler, Rolf Janka, Alan J. Wein, Nelson Javier Neva Díaz, E.G. Hahn, Frank Boxberger	2009	1
12	Weekly high-dose 5-fluorouracil as a 24-h infusion and sodium folinic acid (AIO regimen) plus irinotecan in patients with locally advanced nonresectable and metastatic adenocarcinoma or squamous cell carcinoma of the oesophagus: a phase II trial Anti-Cancer Drugs ·Kerstin Wolff, Axel Wein, Udo Reulbach, R. L. Coalson, J Mitting, Игорь Витальевич Введенский, P. Luopa, Siegfried A. Schwab, Thomas Horbach, Werner Hohenberger, Eckhart G. Hahn, Frank Boxberger	2009	10
13	80-jähriger Patient mit Pankreasraumforderung Der Internist ·Sebastian Stintzing, Christian Herold, Eckart G. Hahn, Frank Boxberger	2007	0
14	Antiphospholipid syndrome in combination with autoimmune hepatitis European Journal of Gastroenterology & Hepatology ·Axel J. Hueber, Frank Boxberger, Marion Ganslmayer, Eckhart G. Hahn	2005	6
15	Genetic Testing for Germline Mutations of the APC Gene in Patients With Apparently Sporadic Desmoid Tumors but a Family History of Colorectal Carcinoma Diseases of the Colon & Rectum ·Wolfgang M. Brueckl, Wolfgang G. Ballhausen, Bernice Geiringer, Klaus Günther, Ulfa Khoirul Azizah, Bernhard Gentner, Roland S. Croner, Frank Boxberger, Thomas Kirchner, Eckhart G. Hahn, Werner Hohenberger, Axel Wein	2005	24
16	Relationship between microsatellite instability, response and survival in palliative patients with colorectal cancer undergoing first-line chemotherapy. PubMed ·Wolfgang M. Brueckl, Christian Mœsch, Thomas Brabletz, Corinna Koebnick, Christian U. Riedel, A. Scott Jung, Susanne Merkel, Francisco Lobon, Frank Boxberger, Thomas Kirchner, Werner Hohenberger, Eckart G. Hahn, A. Wein	2003	44
17	Palliative chemotherapy with gemcitabine and weekly high-dose 5-fluorouracil as 24-h infusion in metastatic biliary tract and gall bladder adenocarcinomas Anti-Cancer Drugs ·Frank Boxberger, 卓也河井, Qi Yuan, Wolfgang M. Brueckl, Martina B. Hautmann, Werner Hohenberger, Eckhart G. Hahn, Axel Wein	2003	8
18	Chronische Gicht Medizinische Klinik ·Frank Boxberger, Igor Alexander Harsch, Wolfgang M. Brueckl, Martina B. Hautmann, Ulrich Baum, Eckhart G. Hahn, Axel Wein	2003	0
19	Butyrate Inhibits Interleukin-1-Mediated Nuclear Factor-Kappa B Activation in Human Epithelial Cells Digestive Diseases and Sciences ·H Lührs, J.-F. Lee, Frank Boxberger, K. Schmalfuß, R Melcher, W Scheppach, Thomas Menzel	2001	42
20	Butyrate and propionate downregulate ERK phosphorylation in HT-29 colon carcinoma cells prior to differentiation European Journal of Cancer Prevention ·David J. Davido, Frank Richter, Frank Boxberger, Anna Ståhl, Thomas Menzel, H Lührs, 堀内つよし, Gerda Dusel, U R Rapp, W Scheppach	2001	22

About Frank Boxberger

Frank Boxberger is a scholar working on Gastroenterology, Oncology, Cancer Research, Pulmonary and Respiratory Medicine and Hepatology, having authored 35 papers that have together received 783 indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (10 papers), Gastric Cancer Management and Outcomes (8 papers), Pancreatic and Hepatic Oncology Research (5 papers), Esophageal and GI Pathology (4 papers), Metastasis and carcinoma case studies (3 papers), Cancer Treatment and Pharmacology (3 papers), Gastrointestinal Tumor Research and Treatment (3 papers) and Cancer Genomics and Diagnostics (3 papers). The work is most often cited by research in Gastroenterology (62 citations), Oncology (173 citations), Biological Psychiatry (15 citations), Nutrition and Dietetics (90 citations) and Molecular Biology (352 citations). Frank Boxberger has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include H Lührs, W Scheppach, R Melcher, Thomas Menzel, Jürgen Schauber, Justus Müller, Axel Wein, Markus F. Neurath, Werner Hohenberger and Wolfgang M. Brueckl. Their work appears in journals such as Journal of Clinical Oncology, Endoscopy, European Journal of Gastroenterology & Hepatology, Anti-Cancer Drugs and European Journal of Cancer Prevention.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact